Hamilton Journal News : 2019-02-11

4 : 4 : 4

4

A4 | JOURNAL-NEWS | MONDAY, FEBRUARY 11, 2019 COMPLETE. IN- DEPTH. DEPENDABLE. MORE OF TODAY’S TOPNEWS DIGGINGDEEPER If some proposals become laws, court are certain. drugs give the state’s Medicaidagencydiscounts beyond set by federal statute. Vertex, the manufacturer ofacysticfifififififibrosismedication witharetail priceof$272,000 ayear, refused. AndNewYork was forced to acknowledge it couldnotrequirecompliance. Vertex touted the effifficacy ofitscysticfifififififibrosisdrug.“The priceofourmedicines reflflect the value they bring to patients,” saidSarah D’Souza, a Vertex spokeswoman, adding,“We do not believe an additional rebate is warranted.” Still, states see promise in that approach. Massachusetts Gov. Charlie Baker, a Republican, recently proposed ameasure that would enable the state Medicaid agency to negotiate further discounts on certain drugs. If negotiations don’twork, the state could subject the manufacturer to a public rate-setting process, require more transparency on pricing, or refer the matter to the state’s attorney general’s offiffice for possible prosecution consumer protection laws. Legislators in Connecticut and Maryland are pushing similar proposals. State lawmakers in Massachusetts, Minnesota, New York and Virginia also want to prevent drugmakers from steep year-to-year price increases in the commercial market. LindaGorman, director of theHealthCarePolicyCenter, attheIndependenceInstitute, a libertarianthinktankbased in said interfering in the market is a bad idea. “It’s a waste of time, and you’ll only endupwithmore regulation and higher prices,” Gormansaid. She argues, for example, that by requiring drugmakers togive discounts to Medicaid agencies, the federal government drivesupdrug prices in commercial plans. therapeutic class, one medicationmayworkbetter another for an individual patient. Some organizations that represent people with certain diseases joined drug manufacturers in objecting toMassachusetts’ proposal. TheTrumpadministration alsoopposes statesimporting cheaper drugs fromCanada. Lastyear, Vermontbecame thefifififififirststatetopursueimportation. Vermont’s measure would save the commercial between $1 million and $5 million a year, astatereport estimated. LawmakersinColorado, Connecticut, Illinois, Maryland, Missouri, Oregon and Virginia have proposed studies of the idea. than those fifights ByMichael Ollove TribuneNewsService Frustrated by federal inaction, state lawmakers in 41 states have proposeddetailedplans to lower soaring prescription drug costs. Somemeasureswould give state Medicaid agencies morenegotiatingpower. Otherswoulddisclose thepricing decisions of the drugmanufacturers and the companies that administer prescription drug plans. The more ambitious proposalswouldbumpupagainst federal authority, such as legislation that would allow drugs from Canada or alter federal statutes on the prices states pay for drugs in Medicaid. They likely would have to survive a challenge in federal court. And many likely would face resistance froma deep-pocketed pharmaceutical industry. According to the National Institute onMoney and Politics, a nonprofifit that campaign data, the pharmaceutical industry in 2018 contributed nearly $19 million to state campaigns, and $56 million to federal ones. “Statesarelimitedinpower in this area,” Sachs, a health law expert at Washington University in St. Louis School of Law. “But of the impacts of these efffffffffffforts is to put pressure on federal government, and force it to justify its actions to stymie the states.” President Donald Trump has criticized soaring drug prices, on Thursday Department of Health and Human Services announced a draft regulation thatwould allow drugmakers to offer discounted prices directly WASHINGTON— Rep. Elijah Cummings (left) the chairman of the HouseOversight and Government Reform Committee, has praisedwhat he said is a bipartisan consensus that drug companies’ aggressive price hikes need to be reined in. Alex Azar (right), secretary ofHealth and Human Services, announced earlier this week a draft regulation thatwould allow drugmakers to offffer discounted prices directly to consumers. significant insurance industry ANDREWHARRER / TOMBRENNER / THE NEWYORK TIMES BLOOMBERG 2018 other few bills offffffffffffered this session would force actions either from or pharmacy benefifit managers, the companies that administer drug plans. Other proposalswould study foreign drug importationorencouragepricenegotiations to benefifit, say, Medicaid patients. The federal government has zealously guarded its authority drug pricing. Last year, for example, the Trump administration rejected Massachusetts’ request to become the state toexcludecertain drugs fromits Medicaid program, to extract better prices from pharmaceutical companies. By law, all state Medicaid agencies must carry every drug approved by the U.S. Food and Drug Administration, in return for rebates from drugmakers. Massachusetts proposed to offffffffffffer at least in every “therapeutic class,” that is, treatments intended to address a specifific condition or illness, such as blood clots or angina. It also sought the authority to evaluate the effffffffffffectiveness of newly introduced drugs, by comparing them with other medicines in the same class. That idea worries some health analysts, who note that even within the same DouglasHoltz-Eakin, presidentoftheself-described “center- right” American ActionForum, toldtheRepublican-ledSenateFinanceCommittee that government policies were at least partly to blamefor rising drug prices. Holtz-Eakincitedlaws governing Medicaid payments to drug companies and the Affordable Care Act’s tax on manufacturers and importers. “It should not be surprising,” hesaid, thatdrugprices simultaneously with the passage of ACA. Priscilla VanderVeer, a spokeswoman for the Pharmaceutical Research Manufacturers of America, to consumers — but without giving rebates to Medicaid managed care organizations or the middlemen known as pharmacy benefifit managers. Between 2012 2017, drug spending in theUnited States increased nearly 29 percent while health spending rose less 25 percent. 2013, the growth in prescription drug spending has exceeded GDP growth, which means the industry is consuming an increasingly large share of the U.S. economy. Committeesinbothhouses of Congress held hearings in January to consider how to arrest the trend. In his opening statement, U.S. House Oversight CommitteeChairmanElijahCummings, a Maryland Democrat, praised what he said is a bipartisan consensus that drug companies’ aggressive price hikes need to be reined in. “We have seen after time that drug companies make money hand over by raising prices of drugs— oftenwithout justifification, and sometimes overnight— while patients are left holding the Cummings said in his statement, adding later: “We have a duty to act now.” On the other insurers ButbuyingdrugsfromCanadarequiresfederalapproval, which, until recently, seemed U. S. Health Human Services Secretary AlexAzar last spring saidseveral times he had no in allowing Vermont or other states to proceedwith such a plan. But in response to some dramatic increases in drug prices, he softened his position, at least in the case of some generic produced by a single manufacturer. Hesaidlast summer thathewas settingupaworking groupto study importing drugs from abroad. Maryland’s attempt to control drug prices ran aground last year in a federal courtroom. The 4th Circuit Court of Appeals inApril threwout a 2017Maryland lawenacted to curb “unwarranted” price hikes, saying the statehadno authority to regulate interstate commerce. Knowing that states are onshaky ground, somedrug companieshavepushedback against attempts to limit their prices. They did so in New York, where lawmakers in 2017 enacted a requirement that makers of certainhigh-priced and importing unlikely. and overall than interest Since over increases under fifirst increased the medications collects fifinance and thelobbyingarmoftheindustry, saidPhRMA, as the group is known, would oppose many of the state bills. The proposals wouldn’t lower pricesonmedications, she said, andwould discourage corporate investment in research and development of new drugs. “Weabsolutelyunderstand where patients are coming from, and their struggles to get the medications they need at an affffffffffffordable price,” VanderVeer said. “But let’s focusonthe entire not just manufacturers.” It isn’t the case, though, that lawmakers are focusing only onmanufacturers; a enacting set said Rachel onemedicine one Denver, time the fifist their the overall and the chain, bill,” side of CapitolHill, “My nephew, Kevin, here has already figured out how to get into your attic. Introductory Price! LOW AS $ 1945 each A gifted lad.” “What up?” Actual size is 40.6 mm Just Released: Secure Your New U.S. 2019 Silver Dollars Now! M Timing is Everything illions of people collect the American Eagle Silver Dollar. In fact, it’s been the country’s most popular Silver Dollar for over thirty years. So when a new mintage of Silver is released, of those same people are already standing in line, ready to secure the freshest silver coins straight from the United States Today, you can count yourself the world’s top collectors by securing freshly struck 2019 U.S. Silver Dollars. Our advice? Keep this stunning offer to yourself. Once word out 2019 Silver Dollars finally available, especially at such a great you’ll be facing far more competition for very first 2019 Silver By calling today, get of the rush. gets that are Dollars price, those many Dollars. you ahead Mint. Call Now And Beat the Crowd! among The American Eagle Silver is one of the best selling most widely collected silver coins in world. miss out — call now and secure your very American Eagle Silver The more you buy, the more you save! Dollar and the Alittle urban squirrel primer.Your gutters are with leaves,needles, seeds and whatnot. Huge attractivenuisance. Pureand simple.And withwinterhere, that attic spaceappeals. C’mon, squirrels arenot idiots.Nextthing youknow, they’ve chewedtheir wayintoasecond home: your attic. Don’t fifilled 2019’s Brand-New Silver Dollar own Dollars. this strictly limited you can now secure these one Troy ounce U.S. Silver in Brilliant Uncirculated (BU) condition. The 100-year- design features a walking Lady Liberty draped in a U.S. flag paired with a majestic shielded S. Eagle. Through release, hefty Dollars 2019 American Eagle Silver Dollar BU 1-4 Coins - $19.95 ea 5-9 Coins - $19.55 ea 10-19 Coins - $19.50 ea 20+ Coins - $19.45 ea + s/h + s/h + + old FREE SHIPPING FREE SHIPPING U. Keep the next generation of gutter lovers— and every other nuisance— out of your gutters for good. you off that dangerous ladder for good. Have us install LeafGuard. The one-piece, hooded gutter system guaranteed never to clog. Or we for free. The Most Affordable Metal— GOVERNMENT GUARANTEED FREE SHIPPING on 8 or More! Precious Limited time only. Product total over $149 before taxes if any). Standard domestic shipping only. Not on previous purchases. ( And Silver is by far the most affordable of all precious metals — and each S. Silver is government-guaranteed for its weight, 99.9% purity legaltender status. valid U. ® Dollar clean them Call today toll-free for fastest service and 1-888-835-8675 And now through 2/28/19 A Coin Flip You Can’t Afford to Lose 75% Off Offer Code AES280-02 Please mention this code when you call. Why are we releasing the most popular Silver Dollar in America for a remarkably affordable price? To introduce to what hundreds of of collectors and satisfied customers have since 1984 — GovMint.com is installation labor on LeafGuard brand gutters, the patented one-piece seamless gutter system. ® you thousands Some restrictions apply.Call fordetails. known the best source for coins worldwide. • 14101 Southcross Dr. W., Suite 175 Dept. AES280-02 • Burnsville, MN 55337 GovMint.com GovMint.com® is a retail distributor of coin currency issues and is not affifiliated with U.S. government. The collectible coin market is unregulated, highly speculative and involves risk. GovMint.com reserves the right to decline to consummate any sale, within its discretion. Facts, fifigures populations deemed accurate as of the date of publication but may change over time. All purchases are expressly conditioned upon your acceptance of GovMint.com’s Terms and Conditions (www.govmint.com/terms-conditions or call 1-800-721-0320); to decline, return your purchase within 30 days of receipt. © 2019 GovMint.com. All rights reserved. and the and signifificantly I 1-888-350-9173 Call for a free estimate: www.gutterscincinnati.com PRINTED AND DISTRIBUTED BY PRESSREADER PressReader.com +1 604 278 4604 ORIGINAL COPY . ORIGINAL COPY . ORIGINAL COPY . ORIGINAL COPY . ORIGINAL COPY . ORIGINAL COPY COPYRIGHT AND PROTECTED BY APPLICABLE LAW

© PressReader. All rights reserved.